Home
Sangamo Therapeutics, Inc.

Sangamo Therapeutics, Inc. Market Share Analysis for August 2026

Sangamo Therapeutics, Inc. is an American biotechnology company based in Brisbane, California. It applies cell and gene therapy to combat haemophilia and other genetic diseases.

Science and Education > Biology

Domainsangamo.com

Year Founded1995

Employees201 - 500

Annual Revenue$100M - $200M

Sangamo Therapeutics, Inc.

Sangamo Therapeutics, Inc. (including company regionals)

sangamo.com

See more website traffic and engagement information

Sangamo Therapeutics, Inc. Revenue up to August 2026 is 100M - 200M

revenue generated by Sangamo Therapeutics, Inc. top domains

Sangamo Therapeutics, Inc. top domains revenue over 3 years

Revenue for Sangamo Therapeutics, Inc. top domains

sangamo.com100M - 200M

See more with Sales Intelligence

Total visits to Sangamo Therapeutics, Inc.'s top domains

Understand Sangamo Therapeutics, Inc. market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

sangamo.com37.6K

See more with Sales Intelligence

Avg. visit duration in Sangamo Therapeutics, Inc.'s top domains

Analyze Sangamo Therapeutics, Inc. engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

sangamo.com00:01:11

See more with Sales Intelligence

Avg. pageviews on Sangamo Therapeutics, Inc.'s top domains

See how Sangamo Therapeutics, Inc. keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

sangamo.com1.74

See more with Sales Intelligence

Sangamo Therapeutics, Inc. top competitors by domain

Top similar sites in August 2026, ranked by their affinity

somalogic.comCompany NameSomaLogicEmployees201 - 500HQUnited States, Colorado, BoulderAnnual revenue$75M - $100MTotal visits11.6KScience and Education > Biology

Top technologies used by Sangamo Therapeutics, Inc.

These are the website technologies, by industry, used by Sangamo Therapeutics, Inc. top domains

Conversion & Analytics (4)

Google Analytics

Widget (4)

reCAPTCHA

Advertising (3)

DoubleClick

Audio Video Media (3)

YouTube

More Technologies

12

See all

News & Signals from Sangamo Therapeutics, Inc.

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsSangamo Therapeutics, Inc. sold assets to Surplus Solutions, LLC. on Aug 20th '26.LIVERMORE, CA, UNITED STATES, September 9, 2026 / EINPresswire.com / - Surplus Solutions, a leader in Equipment Lifecycle Management (ELM) services, today announced that it has acquired laboratory and cGMP manufacturing equipment from the estate of Sangamo Therapeutics, Inc., and will offer the assets to the market through two timed online auctions this fall.

NewsSangamo Therapeutics, Inc. sold assets to PTC Therapeutics, Inc. in the amount of $111M on Aug 13th '26.Following a court-approved bidding process, Sangamo will sell its investigational Fabry disease gene therapy isaralgagene civaparvovec to PTC for $111 million at closing, as well as up to $100 million in potential milestone payments.